Suratwwala Busi. (SBGLP)
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹25.52 |
| Market Cap | ₹442.56 Cr |
| P/E Ratio | 11.87 |
| ROCE | 12.43% |
| ROE | 42.54% |
| Dividend Yield | 0.47% |
| Profit Growth | 71% |
| Debt/Equity | 0.75 |
| Sales Growth | 167.6% |
| Promoter Holding | 73.39% |
| 52-Week Range | ₹18.35 — ₹40.9 |
| Sector | Realty |
| Book Value | ₹5.97 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Let me look at this. A 1,223.58% sales growth and 1,000% profit growth would cause euphoria on Dalal Street, but I learned long ago that a donkey that talks for one day is still a donkey. Suratwwala Busi has a quarterly revenue of just ₹42 crore and a net profit of ₹11 crore. That is a tiny base, and percentage growth from a small number can mislead you. The balance sheet is not terrible: debt/equity is 0.74 and the Piotroski score of 7/9 suggests recent financial health. A promoter holding of 73.39% is a genuine positive; owners and minority shareholders are aligned. ROE of 42.54% grabs the headline, but ROCE of only 12.43% tells me much of that return is manufactured by leverage and a narrow book value of ₹3.47. Paying ₹27.08, or 7.8 times book, leaves little room for error. A cyclical real estate developer with D/E of 0.74 and negligible dividend yield of 0.34% is not a compounder I can sleep on. The P/E of 16.43 looks reasonable, and the PEG of 0.01 is almost a joke; an earnings growth rate of 1,000% cannot be projected forward. I prefer the certainty of a durable franchise, not bursting quarterly numbers. FairStock scores it 60/100, 'steady', but high growth with high leverage in a cyclical business is not 'steady' in my vocabulary. If execution continues, this could be a fast grower; if credit tightens or demand slows, the trap door opens. I would need a much larger margin of safety.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer